|
|
|
Insider
Information: |
Love Richard L |
Relationship: |
Director |
City: |
San Antonio |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
122,528 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$670,126 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
122,528 |
|
|
Total
Value |
$670,126 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PAREXEL International |
PRXL |
Director |
2017-09-29 |
0 |
2003-10-24 |
0 |
Premium* |
|
Imarx Therapeutics Inc |
SEGI |
Director |
2008-05-30 |
48,810 |
2007-07-26 |
0 |
Premium* |
|
Cti Biopharma Corporation |
CTIC |
Director |
2017-09-29 |
73,718 |
2007-09-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRXL |
PAREXEL International |
Director |
|
2012-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,211 |
105,741 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2012-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
71,429 |
263,510 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2013-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
109,891 |
345,308 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2013-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(28,093) |
235,417 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2013-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
86,957 |
409,265 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2013-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,277 |
94,018 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
146,000 |
549,265 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
34,844 |
544,109 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2014-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,662 |
90,680 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2015-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,420 |
86,770 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2015-12-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(58,320) |
472,129 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,695 |
535,824 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2016-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,369 |
86,479 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2017-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,736 |
88,318 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2017-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,823 |
88,302 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2017-09-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(88,302) |
0 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2017-09-29 |
4 |
S |
$3.20 |
$3,123 |
D/D |
(976) |
73,718 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2010-05-24 |
4 |
AS |
$0.37 |
$4,238 |
D/D |
(11,300) |
1,436,112 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-08-15 |
4 |
OE |
$8.49 |
$4,245 |
D/D |
500 |
91,618 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-11-21 |
4 |
OE |
$9.15 |
$4,575 |
D/D |
500 |
100,530 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2013-12-17 |
4 |
S |
$1.71 |
$10,266 |
D/D |
(6,000) |
403,265 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-02-22 |
4 |
OE |
$6.55 |
$11,110 |
D/D |
1,648 |
91,118 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2003-10-24 |
4 |
B |
$15.52 |
$15,520 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2015-09-30 |
4 |
S |
$1.45 |
$19,853 |
D/D |
(13,660) |
530,449 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2008-10-30 |
4 |
B |
$10.34 |
$20,680 |
D/D |
2,000 |
67,307 |
2.39 |
- |
|
82 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|